tirzepatide phase 3 trial 80 weeks weight change for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled The Next Frontier of Weight – Daniel J Drucker on X:

The drug isnt the whole strategy

When appetite vanishes, and each bite needs to be planned, what you eat first is important

Given the heavy reliance of many cancer cells on the transport activity of system xc , this component has emerged as a promising target for the development of anti-cancer drugs

Zhao and Moore, 2018) strikingly reversed that dogma, opening the possibility to employ stem cells as new tools for therapeutic purposes in neural regeneration/repair in diseases and after injuries (Figure 6)

Drucker points out that even early versions of the drugs, which didnt lead to much weight loss, still reduced MACE by around 20%

GLOW Blend: BPC-157/TB-500/GHK-Cu (70mg) Pharmacy Grade GLOW Stack At-Home Blood Test Research Supplies Disclosure: supply links may earn PDP a commission at no cost to you